| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $26,703,139 ) (Continued on the next page) |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 00 | 1 | CDC | 8/31/2023 | $480,635 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA058367 | PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study | 000 | 1 | NIH | 8/31/2023 | $952,946 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21AI167369 | Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids | 000 | 2 | NIH | 6/15/2023 | $212,500 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA055488 | Persistent HIV-1 expression and microglia dysfunction | 000 | 3 | NIH | 5/31/2023 | $739,881 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 002 | 3 | SAMHSA | 6/27/2023 | $370,244 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK118267 | Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury | 001 | 4 | NIH | 3/21/2023 | $546,108 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA013582 | Clinical Addiction Research and Education (CARE) Program | 000 | 22 | NIH | 5/31/2023 | $374,970 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU58DP007538 | CHAMPS National | 00 | 1 | CDC | 7/11/2023 | $2,000,000 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 2 | NIH | 6/2/2023 | $175,382 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | UT939477 | Support for Fetal Alcohol Spectrum Disorders (FASD) prevention, identification, and intervention | 02 | 3 | HRSA | 5/30/2023 | $956,211 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 000 | 4 | NIH | 3/14/2023 | $184,922 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34MH134077 | Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial | 000 | 1 | NIH | 8/16/2023 | $740,235 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33AA027597 | Records for Alcohol Care Enhancement (RACE) | 004 | 5 | NIH | 8/9/2023 | $333,043 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | MC142074 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 00 | 3 | HRSA | 5/25/2023 | $958,194 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 001 | 3 | NIH | 8/17/2023 | $75,573 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 000 | 7 | NIH | 1/30/2023 | $440,994 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | D3349076 | Preventive Medicine Residency | 00 | 1 | HRSA | 4/12/2023 | $399,997 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 000 | 1 | NIH | 9/23/2023 | $161,856 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 3 | NIH | 5/9/2023 | $186,584 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | H1224845 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 11 | HRSA | 6/23/2023 | $419,096 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 001 | 1 | NIH | 9/25/2023 | $161,856 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK133940 | New Therapeutic Leads for Proteinuric Kidney Diseases | 000 | 2 | NIH | 5/16/2023 | $267,000 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P01AA029541 | The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | 003 | 3 | NIH | 8/23/2023 | $377,296 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9830371 | Awareness and Access to Care for Children and Youth with Epilepsy | 02 | 7 | HRSA | 7/24/2023 | $416,000 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AI145661 | HIV-1 mucosal transmission and persistence | 000 | 5 | NIH | 3/13/2023 | $181,673 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 001 | 1 | NIH | 9/25/2023 | -$161,856 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HS028814 | Implementing Telemedicine to Improve Appropriate Antibiotic Prescribing for Acute Respiratory Tract Infections | 001 | 2 | AHRQ | 5/11/2023 | $495,441 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P01AA029541 | The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | 002 | 3 | NIH | 8/10/2023 | $1,423,003 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 000 | 3 | NIH | 4/4/2023 | $166,320 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32HS022242 | Training in Health Services Research for Vulnerable Populations | 000 | 11 | AHRQ | 6/27/2023 | $339,630 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08DA058052 | Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder | 000 | 1 | NIH | 5/9/2023 | $189,205 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P01AA029541 | The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | 001 | 2 | NIH | 11/18/2022 | $109,899 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 3 | NIH | 3/23/2023 | $218,848 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers among Public Housing Residents | 000 | 4 | NIH | 6/7/2023 | $179,376 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166608 | Disease-specific risk factors for thrombosis following vascular interventions | 000 | 1 | NIH | 8/2/2023 | $694,135 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08AI166125 | Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection | 001 | 2 | NIH | 8/1/2023 | $193,752 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI172843 | Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission | 000 | 2 | NIH | 7/18/2023 | $703,914 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL145126 | Improving Prehospital Pediatric Emergency Readiness with Telemedicine | 000 | 4 | NIH | 8/1/2023 | $166,321 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA046527 | Researching Effective Strategies to Prevent Opioid Death (RESPOND) | 001 | 6 | NIH | 9/15/2023 | $895,767 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 000 | 2 | NIH | 6/30/2023 | $648,126 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL155451 | Targeting PGC-1a for the treatment of sickle cell disease | 000 | 2 | NIH | 5/5/2023 | $350,000 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 2 | NIH | 3/1/2023 | $189,432 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA054363 | Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN) | 001 | 3 | NIH | 5/19/2023 | $189,432 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AT010487 | Improving Access to Chiropractic Care for Low Back Pain in Underserved Primary Care Settings: Development and Evaluation of a Multi-level Implementation Strategy | 000 | 5 | NIH | 7/28/2023 | $159,823 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 00 | 2 | DHHS/OS | 9/21/2023 | $269,621 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH127308 | Adaptation and assessment of a common element treatment protocol designed to improve mental health in forcibly displaced populations | 000 | 2 | NIH | 3/24/2023 | $187,013 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DE029862 | Validation of Light Scattering Spectroscopy for Intra-operative Margin Guidance during Oral Cancer Resection | 000 | 4 | NIH | 6/1/2023 | $717,253 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI147316 | Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL) | 000 | 5 | NIH | 8/3/2023 | $238,555 |
| | 2023 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI147316 | Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL) | 000 | 5 | NIH | 8/3/2023 | $688,202 |
|
